Generating Clinically Actionable Tissue Biomarker Data in Complex Diseases Webinar

Generating Clinically Actionable Tissue Biomarker Data in Complex Diseases: Spotlight on Immuno-Oncology and Dermatology
Thursday, November 17, 2022
9:00 AM ET | 3:00 PM CET (Duration: 35 Minutes)
Webinar with Live Q&A

Understanding the mechanism of action or proof of concept following drug treatment may require a detailed analysis of what is happening within tissues.

Multiplex immunofluorescence is a useful approach for generating detailed information on tissues through immunophenotyping and spatial analysis pre- and post-treatment. While often applied in the immune-oncology field, this approach is also useful in autoimmune diseases and dermatology, where it is possible to source clinical biopsies more routinely.

This webinar takes a deeper dive into these complex diseases and covers important points to consider for the successful development and use of tissue-based biomarker assays.

Key points covered:

Approaches for tissue-based interrogation of protein biomarkers
Clinically actionable data – considerations for assay type and level of validation required
How to maximize the utility of clinical samples
Examples from immuno-oncology and dermatology